
Michael Kloss, eureKing CEO
Manufacturing-centric SPAC makes a deal to combine with French CDMO
As smaller biotechs outfits are looking to go public, the special purpose acquisition company, or SPAC, space has been quite an attractive alternative. Most recently, one SPAC is looking to make moves in the manufacturing space.
eureKing, a healthcare SPAC focused on biomanufacturing and production, has submitted an offer to acquire the French contract manufacturer Skyepharma for an undisclosed amount. Skyepharmahas been in business since 1996, producing tablets, capsules and other forms of oral medicines.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters